Truist analyst Bill Chappell lowered the firm’s price target on Procter & Gamble to $180 from $185 and keeps a Buy rating on the shares. The firm updates its model after the company’s Q3 results and FY25 guidance cut, also reducing its FY25 EPS view to $6.77 from $6.90 and its FY26 view to 7.09 from $7.33, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble Unveils New Supply Chain Strategy
- PG Earnings: Procter & Gamble Stock Battered as Shoppers Warned Tariff Troubles Mean Higher Prices
- Goldman Declares ‘Unprecedented’ $154 Billion Rush Into U.S. Equities Despite Tariff Fears
- Procter & Gamble says planning for a ‘wide outcome’ in Q4
- Procter & Gamble says consumers’ logical response to tariffs is to ‘pause’